3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend

Bulletin Express

08/17

3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:

1. Approval of the unaudited interim results for the six months ended 30 June 2026. 2. Consideration of an interim dividend, if any.

Board Composition (as of the announcement date, 17 August 2026): • Executive Director and Chairman: Dr. Gong Zhaolong • Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen • Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang

The notice was issued in Hong Kong on 17 August 2026.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1143007118"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1143007118\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1143007118?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 21:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1143007118","market":"us","top_or_hot":-1,"title":"3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend","media":"Bulletin Express","content":"<p>3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:</p>\n<p>1. Approval of the unaudited interim results for the six months ended 30 June 2026.  \n2. Consideration of an interim dividend, if any.</p>\n<p>Board Composition (as of the announcement date, 17 August 2026):  \n• Executive Director and Chairman: Dr. Gong Zhaolong  \n• Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen  \n• Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang</p>\n<p>The notice was issued in Hong Kong on 17 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3D Medicines Sets 31 Aug 2026 Board Meeting to Review H1 2026 Results and Potential Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-17 21:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:</p>\n<p>1. Approval of the unaudited interim results for the six months ended 30 June 2026.  \n2. Consideration of an interim dividend, if any.</p>\n<p>Board Composition (as of the announcement date, 17 August 2026):  \n• Executive Director and Chairman: Dr. Gong Zhaolong  \n• Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen  \n• Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang</p>\n<p>The notice was issued in Hong Kong on 17 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01244","symbol_name":"思路迪医药股份","start_time":0,"source_url":"","article_id":"1143007118","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1143007118","pubTimestamp":1786974313,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes: 1. Approval of the unaudited interim results for the six months ended 30 June 2026.   2. Consideration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01244":"思路迪医药股份"},"translate_title":"3D Medicines 定于 2026 年 8 月 31 日召开董事会会议，审查 2026 年上半年业绩和潜在中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01244":1},"content_text":"3D Medicines Inc. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes:\n1. Approval of the unaudited interim results for the six months ended 30 June 2026.  \n2. Consideration of an interim dividend, if any.\nBoard Composition (as of the announcement date, 17 August 2026):  \n• Executive Director and Chairman: Dr. Gong Zhaolong  \n• Non-Executive Directors: Ms. Zhang Wenhua, Mr. Zhou Feng, Ms. Chen Yawen  \n• Independent Non-Executive Directors: Dr. Li Jin, Dr. Lin Tat Pang, Mr. Liu Xinguang\nThe notice was issued in Hong Kong on 17 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}